Latest Headlines

Latest Headlines

AstraZeneca's plan to unite R&D hubs takes flight

Looking to tie its two big R&D hubs in Cambridge, U.K., and Gothenburg, Sweden, closer together, AstraZeneca has struck a deal to reserve 20 seats on a Sun Air flight that will make a round-trip journey each day from Monday through Thursday.

Hospitals purchasing MRI, CT scanners to take real-time images during surgery

The real-time use of MRIs and CT scans during surgery is becoming increasingly prevalent and improving patient outcomes. The images produced by intraoperative imaging techniques allow surgeons to make more precise cuts, thereby sparing healthy tissue and bone, and reducing the need for repeat procedures.

InVentiv brings its Phase I biz to the U.S. with new outpost

CRO giant inVentiv Health is opening an early-stage clinic in Miami, expanding its global Phase I services to the U.S. with an emphasis on complex studies.

Swiss developers debut telescopic contact lens triggered by blinking

Developers have come up with a telescopic contact lens that can alternate between normal and magnified vision with the blink of an eye, and has the potential to help people suffering from macular degeneration.

Low-profile biotech gets $30M, new CEO and new home for PhIII atrial fib effort

A low-profile biotech in Cleveland landed a $30 million B round with the help of a new group of prominent venture backers and has been given a new CEO, a new home in La Jolla and a continuing mission to develop a drug for atrial fibrillation that has quietly moved to the threshold of a Phase III program.

AstraZeneca struggles to spin out anti-infectives division, coming down to the wire

The moment of truth is arriving for AstraZeneca's anti-infectives unit. For more than a year now, the pharma giant has been quietly shopping a deal, seeking an investor willing to take control of the assets, while allowing AstraZeneca to keep a substantial stake for itself, FierceBiotech has learned. Now, industry insiders are buzzing that the company is coming down to the wire on a final decision--and that throughout the negotiations, staffers have been steadily fleeing the once-sizable operation.

Microsoft, Cambridge University team up on blood cancer simulation model

Researchers have created a computer model to simulate blood cell development. The model can simulate the activity of genes tied to blood cancers, giving researchers a quick way to map the pathways that play out in leukemia and other diseases.

Medidata's wearables wish list: Long battery life and water resistance

Medidata has struck a deal with Garmin to offer its clients the use of vívofit activity trackers in clinical trials. The choice of vívofit gives an indication of the characteristics clinical trial sponsors may prioritize as wearables start to take off in research.

Ex-J&J exec turns to crowd to fund brain disorder simulation project

The former head of Johnson & Johnson's initiative to develop stratified drugs for Alzheimer's disease is trying to crowdfund the development of computer simulations of brain disorders. Magali Haas is seeking $299,900 for the project, which builds on a multiple sclerosis prediction model created by her nonprofit, Orion Bionetworks.

USAID backs wearable tech initiative for Ebola from Scripps

Amid growing efforts to quell the Ebola outbreak, the U.S. Agency for International Development (USAID) is funding a new initiative from the Scripps Translational Science Institute to develop wearable technology to monitor patients with the virus and identify the condition earlier.